Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Papillomavirus Infections 2Breast Neoplasms 2Acquired Immunodeficiency Syndrome 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Sexually Transmitted Diseases 1Ovarian Cysts 1Neoplasms 1Menorrhagia 1Lung Neoplasms 1Leiomyoma 1High-grade Anal Intraepithelial Neoplasia 1HIV Infections 1Endometriosis 1Condylomata Acuminata 1Benign Ovarian Tumor 1Anus Neoplasms 1

Interventions

Trastuzumab 597Paclitaxel 562Cyclophosphamide 545Docetaxel 479Capecitabine 388Letrozole 350Fulvestrant 311Doxorubicin 285Carboplatin 277Tamoxifen 257Anastrozole 219exemestane 211Epirubicin 210Radiotherapy 197Bevacizumab 189pertuzumab 177Gemcitabine 163Vinorelbine 162pembrolizumab 161Lapatinib 161palbociclib 152Exercise 132Fluorouracil 118Albumin-Bound Paclitaxel 116eribulin 108Magnetic Resonance Spectroscopy 108130-nm albumin-bound paclitaxel 107Everolimus 103Taxes 96Cisplatin 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Breast Neoplasms × Electrocoagulation × Clear all
NCT07050329 2025-07-03

Comparison of Operation Time, Drain Duration, and Seroma Formation After Modified Radical Mastectomy Using Ultrasonic Dissector Versus Electrocautery in Women With Breast Cancer

Quaid-e-Azam Medical College

Phase NA Completed
138 enrolled
Breast

Breast Neoplasms

NCT01587248 2012-04-30

HMRM

Aga Khan University

Phase 3 Completed
152 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡